The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Glofitamab step-up dosing (SUD): Complete response rates in updated efficacy data in heavily pretreated relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL) patients (pts).
 
Carmelo Carlo-Stella
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene; Gilead Sciences; Incyte; Janssen Oncology; Merck Sharp & Dohme; Takeda
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; Incyte; Karyopharm Therapeutics; Roche; Sanofi
Research Funding - ADC Therapeutics (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - ADC Therapeutics; Janssen; Roche; Takeda
 
Martin Hutchings
Consulting or Advisory Role - Genmab; Janssen; Roche; Takeda
Research Funding - Celgene (Inst); Genmab (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Fritz C. Offner
No Relationships to Disclose
 
Franck Morschhauser
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Epizyme; Gilead Sciences; Janssen; Roche; SERVIER
Speakers' Bureau - Roche
Expert Testimony - Roche
 
Emmanuel Bachy
Honoraria - Gilead Sciences; Janssen; Novartis; Roche; Sanofi
Consulting or Advisory Role - Incyte; Roche
 
Michael Crump
Honoraria - Gilead Sciences; Servier/Pfizer
Consulting or Advisory Role - Gilead Sciences; Novartis Canada Pharmaceuticals Inc; SERVIER
Research Funding - Roche Canada
 
Anna Sureda Balari
Honoraria - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Novartis; Takeda
Speakers' Bureau - Takeda
Other Relationship - Celgene; Gilead Sciences; Roche; Sanofi; Takeda
 
Gloria Iacoboni
Honoraria - Celgene/Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Roche/Genentech
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Celgene/Bristol-Myers Squibb; Gilead Sciences; Novartis
 
Corinne Haioun
Honoraria - Amgen; Celgene; Gilead Sciences; Janssen-Cilag; Miltenyi Biotec; Roche; Takeda
 
David Perez-Callejo
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Linda Lundberg
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
 
James Relf
Employment - Roche
Stock and Other Ownership Interests - F-Star; Harpoon therapeutics; Roche
 
Emma Clark
Employment - Roche
 
David Carlile
Employment - AstraZeneca; Roche
Stock and Other Ownership Interests - AstraZeneca; Roche
 
Emily Piccione
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Anton Belousov
Employment - Roche
 
Kathryn Humphrey
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Michael J. Dickinson
Honoraria - Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Janssen; Novartis; Roche (I)
Speakers' Bureau - Novartis
Research Funding - Celgene (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche